Download MendeleyIdentification of a novel ligand binding motif in the transthyretin channel.
Lima, L.M., Silva, V.D., Palmieri, L.D., Oliveira, M.C., Foguel, D., Polikarpov, I.(2010) Bioorg Med Chem 18: 100-110
- PubMed: 19954984
- DOI: https://doi.org/10.1016/j.bmc.2009.11.025
- Primary Citation of Related Structures:
3CFM, 3CFN, 3CFQ, 3CFT - PubMed Abstract:
The design of therapeutic compounds targeting transthyretin (TTR) is challenging due to the low specificity of interaction in the hormone binding site. Such feature is highlighted by the interactions of TTR with diclofenac, a compound with high affinity for TTR, in two dissimilar modes, as evidenced by crystal structure of the complex. We report here structural analysis of the interactions of TTR with two small molecules, 1-amino-5-naphthalene sulfonate (1,5-AmNS) and 1-anilino-8-naphthalene sulfonate (1,8-ANS). Crystal structure of TTR:1,8-ANS complex reveals a peculiar interaction, through the stacking of the naphthalene ring between the side-chain of Lys15 and Leu17. The sulfonate moiety provides additional interaction with Lys15' and a water-mediated hydrogen bond with Thr119'. The uniqueness of this mode of ligand recognition is corroborated by the crystal structure of TTR in complex with the weak analogue 1,5-AmNS, the binding of which is driven mainly by hydrophobic partition and one electrostatic interaction between the sulfonate group and the Lys15. The ligand binding motif unraveled by 1,8-ANS may open new possibilities to treat TTR amyloid diseases by the elucidation of novel candidates for a more specific pharmacophoric pattern.
Organizational Affiliation:
Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, RJ 21941-902, Brazil. mauricio@pharma.ufrj.br
